DuPont Launches High-Tech Medical Fabrics to Enhance Protection, Comfort for Healthcare Professionals
WILMINGTON, Del. -- DuPont today introduced an innovative medical fabric, DuPont Suprel, born from a revolutionary composite technology that provides both advanced levels of protection and comfort for healthcare professionals.
Traditional single-use medical fabrics can be uncomfortable, especially when they are worn for an extended time, and can lack the necessary fluid barrier for protecting today's healthcare professionals. Suprel nonwoven is the first in a line of upcoming medical fabrics from DuPont that are both highly protective and silky-soft.
DuPont researchers created Suprel through a unique bi-component formulation using the company's proprietary Advanced Composite Technology. Developing nearly 20 new patents for this technology, DuPont can blend the ideal properties of two different raw materials to create medical fabrics that meet specific needs. For example, Suprel is the only medical fabric available that is made of polyester - for strength - and polyethylene - for silk-like softness. It has less surface friction than other medical fabric products, allowing for greater comfort and freedom of movement. It also transfers heat away from the body quickly, adding to comfort in the operating environment. Suprel is made from continuous filament fibers and is very low linting.
Using a market-focused approach as part of its research and development, DuPont researchers developed Suprel by working closely with operating room nurses who participated in comfort studies conducted at North Carolina State University. Feedback and input on protection and comfort from the healthcare professionals were used in developing the new medical fabric.
"Suprel is the first in a line of innovative products from DuPont that will raise the bar for standards of protection and comfort in medical fabrics," said Lori Gettlefinger of DuPont Medical Fabrics. "Unlike the technology used with single polymer fabrics, this composite fabric technology will allow us to create an array of fabrics in direct response to the evolving needs of the medical industry."
Suprel will be available for commercial distribution in late summer in the U.S. and later this year in Europe and Asia Pacific regions. DuPont will be conducting in-hospital trial evaluations of Suprel for hospitals that request to review the high-tech medical fabric. Hospitals interested in participating in the evaluations can contact DuPont Medical Fabrics at 888-383-6887 or at www.MedicalFabrics.dupont.com.
Source: DuPont
Canada Faces Rising Measles Cases: Public Health Urges Vaccination Amid Growing Threat
March 6th 2025Measles cases in Canada are rising, with 227 infections reported in early 2025. Public health officials urge vaccination to prevent outbreaks, severe complications, and further community transmission.
Surging Whooping Cough Cases Highlight the Importance of Vaccination
March 6th 2025Experts like Michael Glazier, MD, warn that waning immunity, declining vaccination rates, and increased transmission are driving this resurgence. Vaccination remains the best defense, with pediatricians urging timely immunization to protect vulnerable populations and prevent further outbreaks.
Measles Outbreak Sparks APIC’s Urgent Call for Stronger Vaccine Policies
March 4th 2025The recent measles-related death in Texas has reignited fears about the consequences of declining vaccination rates and misinformation. Once declared eliminated in the US, measles is resurging with over 150 cases and climbing. APIC warns: this crisis is preventable—but only if we act now.
